Building owners, facility managers, and HVAC design engineers convince themselves that pharmaceutical and mission critical installations are very sophisticated and more complex than many health care applications and certainly more challenging to engineer, operate, and maintain than commercial buildings. But, that’s not the case.
While many design requirements associated with current good manufacturing practice (cGMP) spaces are required by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others, the engineer must be aware of several factors.
In 2020, Kite Pharma began constructing a new facility in Frederick, Maryland, designed to produce innovative cell therapy treatments for cancer patients.
This white paper from Millig Design Build aims to provide a framework for the different approaches to dehumidification for critical environments looking to reduce energy use and achieve a Net Zero carbon future.
Air cleanliness, space pressurization, required air changes, and equipment placement are just a few of the many important factors that must be considered
Air cleanliness, space pressurization, required air changes, and equipment placement are just a few of the many important factors that must be considered
The existing equipment to remain as part of the condenser water system includes the plate and frame heat exchangers and split-case pumps with standby pumps, each with variable frequency drives (VFDs).
Simplicity and the limited number of HVAC systems within a pharma building make operation, maintenance, and energy conservation performance demanding but easy when compared to health care applications.
The system includes a 2,000-ton open cooling tower with six condenser water pumps and four 500-ton centrifugal electric chillers with two condenser water pumps for process chilled water cooling.